Indobufen API is a reversible platelet aggregation inhibitor used for the prevention of thromboembolic disorders. It works by inhibiting cyclooxygenase and reducing thromboxane A₂ synthesis, thereby decreasing platelet aggregation. Indobufen API is produced under GMP standards and is suitable for oral tablet formulations.

Indobufen API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.